EichorEICHOR
Condition: Mild To Moderate Alzheimer Disease Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Mild To Moderate Alzheimer Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RE
Phase 4 · 5 location(s) · Alpha Cognition, Inc · NCT07633470Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of De
Phase 3 · 1 location(s) · Sichuan Jishengtang Pharmaceutical Co., Ltd. · NCT06534723A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · 116 location(s) · Bristol-Myers Squibb · NCT06976216A Study of NTRX-07 in Participants With Alzheimer's Disease
Phase 2 · 6 location(s) · NeuroTherapia, Inc. · NCT07058688Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · 26 location(s) · GAP Innovations, PBC · NCT06584357Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Phase 2 · 1 location(s) · Duke University · NCT06041789A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · 126 location(s) · Bristol-Myers Squibb · NCT06976203A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
Phase 3 · 1 location(s) · I.R.C.C.S. Fondazione Santa Lucia · NCT06702124Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT04124029Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT06597942A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease
Phase 1/Phase 2 · 1 location(s) · University Hospital, Toulouse · NCT07367815An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
Phase 4 · 50 location(s) · Green Valley (Shanghai) Pharmaceuticals Co., Ltd. · NCT05908695Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheime
Phase 1 · 1 location(s) · Regeneration Biomedical, Inc. · NCT05667649Pulsed Electromagnetic Field Treatment With Dementia Patients
NA · 1 location(s) · Herrick Medical LLC · NCT06862557Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)
Phase 3 · 23 location(s) · Danyang Huichuang Medical Equipment Co., Ltd. · NCT07262645Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Phase 4 · 1 location(s) · University Hospital, Montpellier · NCT05924425The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
Phase 1/Phase 2 · 1 location(s) · Xuanwu Hospital, Beijing · NCT07457125A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
Phase 1/Phase 2 · 10 location(s) · NSC-Therapeutics · NCT06995573Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
NA · 1 location(s) · Herrick Medical LLC · NCT05295615Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease
NA · 6 location(s) · REGEnLIFE SAS · NCT05926011
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.